T1	Procedure 0 13	Re-transplant
T2	Measurement 34 57	panel reactive antibody
T3	Measurement 59 62	PRA
T4	Value 64 85	equal to or above 50%
R1	Subsumes Arg1:T2 Arg2:T3	
T5	Value 87 94	class I
T6	Value 98 106	class II
*	OR T6 T5 T4
T7	Scope 64 106	equal to or above 50%, class I or class II
R2	Has_scope Arg1:T2 Arg2:T7	
T8	Condition 109 132	Acute rejection episode
T9	Temporal 140 152	last 30 days
T10	Measurement 177 191	Banff criteria
T11	Value 165 169	> 2A
R3	Has_value Arg1:T10 Arg2:T11	
R4	Has_temporal Arg1:T8 Arg2:T9	
*	OR T8 T10
T12	Measurement 194 197	GFR
T14	Value 205 216	< 40 ml/min
R5	Has_value Arg1:T12 Arg2:T14	
T13	Condition 219 230	Proteinuria
T15	Multiplier 231 240	> 0,5 g/l
R6	Has_multiplier Arg1:T13 Arg2:T15	
T16	Measurement 243 253	Hemoglobin
T17	Value 254 262	< 10 g/l
T18	Measurement 270 280	leucocytes
T19	Value 281 296	< 4000 cels/mm3
T20	Measurement 304 313	platelets
T21	Value 314 332	< 150.000 cels/mm3
R7	Has_value Arg1:T16 Arg2:T17	
R8	Has_value Arg1:T18 Arg2:T19	
R9	Has_value Arg1:T20 Arg2:T21	
*	OR T16 T18 T20
T22	Measurement 335 348	Triglycerides
T23	Value 349 360	> 500 mg/dl
R10	Has_value Arg1:T22 Arg2:T23	
T24	Drug 384 391	fibrate
A1	Optional T24
T25	Measurement 394 411	Cholesterol total
T26	Value 412 423	> 300 mg/dl
R11	Has_value Arg1:T25 Arg2:T26	
T27	Drug 447 453	statin
A2	Optional T27
T28	Condition 456 477	Hepatic abnormalities
T29	Condition 492 507	periphery edema
T30	Qualifier 480 491	Significant
R12	Has_qualifier Arg1:T29 Arg2:T30	
T31	Condition 510 533	Pulmonary abnormalities
T32	Procedure 537 549	breast x-ray
T33	Value 550 563	abnormalities
R13	Has_value Arg1:T32 Arg2:T33	
T34	Condition 566 583	Hyper sensibility
T35	Drug 587 596	sirolimus
R14	AND Arg1:T34 Arg2:T35	
